Erratum to: A phase I dose-escalation study of Selumetinib...

  • Main
  • 2017 / 7
  • Erratum to: A phase I dose-escalation study of Selumetinib...

Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors

Infante, Jeffrey R., Cohen, Roger B., Kim, Kevin B., Burris, Howard A., Curt, Gregory, Emeribe, Ugochi, Clemett, Delyth, Tomkinson, Helen K., LoRusso, Patricia M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0479-3
Date:
July, 2017
File:
PDF, 279 KB
english, 2017
Conversion to is in progress
Conversion to is failed